Their net income for 2021 was $1058M on about $10B of revenue, so this mostly wipes out 1 year of profits.
¯\_(ツ)_/¯
¯\_(ツ)_/¯
2010-June-30: $1094M
2011-June-30: $1076M
2012-June-30: $1342M
2013-June-30: $1608M
2014-June-30: $2140M
2015-June-30: $3490M
Also, because someone asked, edgar has a bar chart breakdown of Biogen's product revenue. The lawsuit was about Biogen's drugs Avonex, Tysabri and Tecfidera. The bar chart (https://www.sec.gov/Archives/edgar/data/875045/0000875045150...) seems to indicate that these three were responsible for about 80-83% of Biogen's revenues (and presumably net income?) in 2014.
I guess what we don't know is what their sales would have been like without the kickbacks? Less, presumably? But 0? Probably not.
If found guilty, you can be banned from doing any business with Medicare and Medicaid in the US - that’s already a part of the law and it’s the same as losing 50% of your revenue in perpetuity.
But it’s never used. Well, they used it on Pfizer, but the agreement was the ban was for a shell company they owned that didn’t actually sell any drugs. A sacrificial lamb if you will.
“A Pfizer subsidiary, Pharmacia and Upjohn Inc., which was acquired in 2003, has agreed to plead guilty to one count of felony misbranding.”
https://www.dispatch.com/story/news/2009/09/03/pfizer-must-p...